4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-005782
Chief Scientific Officer sold 7,500 shares at an average $13.00 ($97,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| COOKE MICHAEL P. Chief Scientific Officer | 2019-12-02 | Sale | −3,627 | $12.74 | $46,205 | 244,396 | D |
| COOKE MICHAEL P. Chief Scientific Officer | 2019-12-02 | Sale | −1,373 | $13.31 | $18,279 | 243,023 | D |
| COOKE MICHAEL P. Chief Scientific Officer | 2019-12-02 | Sale | −2,500 | $13.21 | $33,036 | 240,523 | D |
| Open-market sales · 7,500 sh · avg $13.00 · $97,520 | |||||||
Loading xslF345X03/primarydocument.xml…